Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]

Xu M, Yao C, Zhang W, Gao S, Zou H, Gao J. Int J Nanomedicine. 2021;16:2735–2749. The authors have advised the Acknowledgment statement on page 2748 is incorrect. The acknowledgment section should read as follows: Acknowledgments The authors acknowledge the formulation for the docetaxel in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xu M, Yao C, Zhang W, Gao S, Zou H, Gao J
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	poly(2-oxazoline)s micelle docetaxel high loading anti-cancer activity Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/9fc910278c4441028ff5b5728c9d220e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9fc910278c4441028ff5b5728c9d220e
record_format	dspace
spelling	oai:doaj.org-article:9fc910278c4441028ff5b5728c9d220e2021-12-02T15:06:13ZAnti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]1178-2013https://doaj.org/article/9fc910278c4441028ff5b5728c9d220e2021-07-01T00:00:00Zhttps://www.dovepress.com/corrigendum-anti-cancer-activity-based-on-the-high-docetaxel-loaded-po-peer-reviewed-fulltext-article-IJNhttps://doaj.org/toc/1178-2013Xu M, Yao C, Zhang W, Gao S, Zou H, Gao J. Int J Nanomedicine. 2021;16:2735–2749. The authors have advised the Acknowledgment statement on page 2748 is incorrect. The acknowledgment section should read as follows: Acknowledgments The authors acknowledge the formulation for the docetaxel in Poly(2-oxazoline) micelles previously developed and published by the Kabanov lab with reference to Seo Y, Schulz A, Han Y, et al. Poly (2-oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors. Polym Adv Technol. 2015;26(7):837–850 (https://doi.org/10.1002/pat.3556).24 The current article reports the authors original research evaluating this polymeric micelle formulation of docetaxel in their own animal models. Dr Jing Gao wishes to acknowledge her time spent as a visiting scholar to the Kabanov lab at UNC-Chapel Hill from 2013-2014. This study was supported by Military Medical Innovation Project (16CXZ032), National Science and Technology Major Projects for “Major New Drugs Innovation and Development” (No. 2018ZX09J18107-003, 2018ZX0 9721003-005-009) and NSFC projects (No. 81773278, 81702491). Read the original articleXu MYao CZhang WGao SZou HGao JDove Medical Pressarticlepoly(2-oxazoline)smicelledocetaxelhigh loadinganti-cancer activityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 4675-4676 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	poly(2-oxazoline)s micelle docetaxel high loading anti-cancer activity Medicine (General) R5-920
spellingShingle	poly(2-oxazoline)s micelle docetaxel high loading anti-cancer activity Medicine (General) R5-920 Xu M Yao C Zhang W Gao S Zou H Gao J Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
description	Xu M, Yao C, Zhang W, Gao S, Zou H, Gao J. Int J Nanomedicine. 2021;16:2735–2749. The authors have advised the Acknowledgment statement on page 2748 is incorrect. The acknowledgment section should read as follows: Acknowledgments The authors acknowledge the formulation for the docetaxel in Poly(2-oxazoline) micelles previously developed and published by the Kabanov lab with reference to Seo Y, Schulz A, Han Y, et al. Poly (2-oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors. Polym Adv Technol. 2015;26(7):837–850 (https://doi.org/10.1002/pat.3556).24 The current article reports the authors original research evaluating this polymeric micelle formulation of docetaxel in their own animal models. Dr Jing Gao wishes to acknowledge her time spent as a visiting scholar to the Kabanov lab at UNC-Chapel Hill from 2013-2014. This study was supported by Military Medical Innovation Project (16CXZ032), National Science and Technology Major Projects for “Major New Drugs Innovation and Development” (No. 2018ZX09J18107-003, 2018ZX0 9721003-005-009) and NSFC projects (No. 81773278, 81702491). Read the original article
format	article
author	Xu M Yao C Zhang W Gao S Zou H Gao J
author_facet	Xu M Yao C Zhang W Gao S Zou H Gao J
author_sort	Xu M
title	Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
title_short	Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
title_full	Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
title_fullStr	Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
title_full_unstemmed	Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]
title_sort	anti-cancer activity based on the high docetaxel loaded poly(2-oxazoline)s micelles [corrigendum]
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/9fc910278c4441028ff5b5728c9d220e
work_keys_str_mv	AT xum anticanceractivitybasedonthehighdocetaxelloadedpoly2oxazolinesmicellescorrigendum AT yaoc anticanceractivitybasedonthehighdocetaxelloadedpoly2oxazolinesmicellescorrigendum AT zhangw anticanceractivitybasedonthehighdocetaxelloadedpoly2oxazolinesmicellescorrigendum AT gaos anticanceractivitybasedonthehighdocetaxelloadedpoly2oxazolinesmicellescorrigendum AT zouh anticanceractivitybasedonthehighdocetaxelloadedpoly2oxazolinesmicellescorrigendum AT gaoj anticanceractivitybasedonthehighdocetaxelloadedpoly2oxazolinesmicellescorrigendum
_version_	1718388532914946048

Anti-Cancer Activity Based on the High Docetaxel Loaded Poly(2-Oxazoline)s Micelles [Corrigendum]

Ejemplares similares